M Jonzier-Perey - JoVE Visualize

Showing results (1-10 of 12) with videos related to

Pageof 2

Sort By:

Clinica Chimica Acta; International Journal of Clinical Chemistry|February 15, 1988

GC and GC-MS procedures for simultaneous phenotyping with dextromethorphan and mephenytoinP Baumann, M Jonzier-Perey

Schweizerische Medizinische Wochenschrift|August 17, 1985

[The use of low-dose amitriptyline in psychogeriatrics. A clinical, pharmacokinetic and pharmacogenetic study]C Schnyder, P Baumann, M Jonzier-Perey, et al.

European Journal of Clinical Pharmacology|January 1, 1985

Interindividual differences in the binding of antidepressives to plasma proteins: the role of the variants of alpha 1-acid glycoproteinD Tinguely, P Baumann, M Conti, et al.

Psychopharmacology|January 1, 1984

Evaluation of the levels of free and total amitriptyline and metabolites in the plasma and brain of the rat after long-term administration of doses used in receptor studiesP Baumann, J M Gaillard, M Jonzier-Perey, et al.

International Clinical Psychopharmacology|April 1, 1986

Amitriptyline pharmacokinetics and clinical response: II. Metabolic polymorphism assessed by hydroxylation of debrisoquine and mephenytoinP Baumann, M Jonzier-Perey, L Koeb, et al.

International Clinical Psychopharmacology|April 1, 1986

Amitriptyline pharmacokinetics and clinical response: I. Free and total plasma amitriptyline and nortriptylineP Baumann, M Jonzier-Perey, L Koeb, et al.

Clinical Pharmacology and Therapeutics|October 1, 1992

Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymesU Breyer-Pfaff, B Pfandl, K Nill, et al.

Therapeutic Drug Monitoring|May 22, 2001

Pharmacokinetic drug interaction potential of risperidone with cytochrome p450 isozymes as assessed by the dextromethorphan, the caffeine, and the mephenytoin testC B Eap, G Bondolfi, D Zullino, et al.

Therapeutic Drug Monitoring|February 1, 1992

Dextromethorphan and mephenytoin phenotyping of patients treated with thioridazine or amitriptylineP Baumann, J W Meyer, M Amey, et al.

Therapeutic Drug Monitoring|April 25, 2000

Steady state plasma levels of the enantiomers of trimipramine and of its metabolites in CYP2D6-, CYP2C19- and CYP3A4/5-phenotyped patientsC B Eap, S Bender, M Gastpar, et al.

Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:

Pageof 2

Clinica Chimica Acta; International Journal of Clinical Chemistry|February 15, 1988

GC and GC-MS procedures for simultaneous phenotyping with dextromethorphan and mephenytoinP Baumann, M Jonzier-Perey

Schweizerische Medizinische Wochenschrift|August 17, 1985

[The use of low-dose amitriptyline in psychogeriatrics. A clinical, pharmacokinetic and pharmacogenetic study]C Schnyder, P Baumann, M Jonzier-Perey, et al.

European Journal of Clinical Pharmacology|January 1, 1985

Interindividual differences in the binding of antidepressives to plasma proteins: the role of the variants of alpha 1-acid glycoproteinD Tinguely, P Baumann, M Conti, et al.

Psychopharmacology|January 1, 1984

Evaluation of the levels of free and total amitriptyline and metabolites in the plasma and brain of the rat after long-term administration of doses used in receptor studiesP Baumann, J M Gaillard, M Jonzier-Perey, et al.

International Clinical Psychopharmacology|April 1, 1986

Amitriptyline pharmacokinetics and clinical response: II. Metabolic polymorphism assessed by hydroxylation of debrisoquine and mephenytoinP Baumann, M Jonzier-Perey, L Koeb, et al.

International Clinical Psychopharmacology|April 1, 1986

Amitriptyline pharmacokinetics and clinical response: I. Free and total plasma amitriptyline and nortriptylineP Baumann, M Jonzier-Perey, L Koeb, et al.

Clinical Pharmacology and Therapeutics|October 1, 1992

Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymesU Breyer-Pfaff, B Pfandl, K Nill, et al.

Therapeutic Drug Monitoring|May 22, 2001

Pharmacokinetic drug interaction potential of risperidone with cytochrome p450 isozymes as assessed by the dextromethorphan, the caffeine, and the mephenytoin testC B Eap, G Bondolfi, D Zullino, et al.

Therapeutic Drug Monitoring|February 1, 1992

Dextromethorphan and mephenytoin phenotyping of patients treated with thioridazine or amitriptylineP Baumann, J W Meyer, M Amey, et al.

Therapeutic Drug Monitoring|April 25, 2000

Steady state plasma levels of the enantiomers of trimipramine and of its metabolites in CYP2D6-, CYP2C19- and CYP3A4/5-phenotyped patientsC B Eap, S Bender, M Gastpar, et al.

Pageof 2